The efficacy and safety of recombinant- versus urinary-human chorionic gonadotrophin in ovulation induction: results of a double-blind clinical study

被引：0
|
作者：
Warne, D
Hughes, JN
Durnerin, IC
Decosterd, G
Loumaye, E
机构：
[1] Ares Serono Int SA, CH-1211 Geneva, Switzerland
[2] Univ Paris 13, Jean Verdier Hosp, Dept Obstet & Gynecol, Ctr Reprod Med, F-93143 Bondy, France
来源：
HUMAN REPRODUCTION | 2000年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
O217
引用
收藏
页码：87 / 87
页数：1
相关论文
共 50 条
  • [1] A prospective double blind study comparing the effects of oxytocin and human chorionic gonadotrophin as trigger for ovulation
    Mehrotra, S.
    Singh, U.
    Gupta, H. P.
    Tandon, I.
    Saxena, P.
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2014, 34 (01) : 13 - 16
  • [2] Recombinant versus urinary human chorionic gonadotrophin for ovulation induction in assisted conception - art. no. CD003719.pub.2
    Al-Inany, HG
    Aboulghar, M
    Mansour, R
    Proctor, M
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (02):
  • [3] Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men
    Liu, PY
    Turner, L
    Rushford, D
    McDonald, J
    Baker, HWG
    Conway, AJ
    Handelsman, DJ
    [J]. HUMAN REPRODUCTION, 1999, 14 (06) : 1540 - 1545
  • [4] Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction:: recombinant human chorionic gonadotrophin (Ovidrel®) versus urinary HCG (Profasi®)
    Mills, J
    Maislisch, L
    Warne, D
    Loumaye, E
    [J]. HUMAN REPRODUCTION, 2000, 15 : 46 - 46
  • [5] Efficacy and safety of Samtropin™ recombinant human growth hormone; a double-blind randomized clinical trial
    Tabatabaei-Malazy O.
    Mohajeri-Tehrani M.R.
    Heshmat R.
    Taheri E.
    Shafiee G.
    Razzaghy-Azar M.
    Rabbani A.
    Qorbani M.
    Adibi H.
    Shahbazi S.
    Karimi F.
    Rezaian S.
    Larijani B.
    [J]. Journal of Diabetes & Metabolic Disorders, 13 (1):
  • [6] Recombinant human luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures:: Results of a multicenter double-blind study
    Engrand, P
    Arguinzoniz, M
    Piazzi, A
    Bologna, S
    Loumaye, E
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (06): : 2607 - 2618
  • [7] Retrospective study of human chorionic gonadotrophin-induced ovulation versus urinary luteinizing hormone surge detection for timing of intrauterine insemination
    Hirata, R
    Habara, T
    Hayashi, N
    [J]. RESEARCH PAPERS IN FERTILITY AND REPRODUCTIVE MEDICINE, 2004, 1271 : 7 - 10
  • [8] Comparison of urinary and recombinant human chorionic gonadotropin during ovulation induction in intrauterine insemination cycles: a prospective randomized clinical trial
    Sakhel, Khaled
    Khedr, Mohamed
    Schwark, Sandra
    Ashraf, Mohammad
    Fakih, Michael H.
    Abuzeid, Mostafa
    [J]. FERTILITY AND STERILITY, 2007, 87 (06) : 1357 - 1362
  • [9] A Randomized study of recombinant versus urinary human chorionic gonadotrophin in Chinese women undergoing assisted reproductive technology cycles.
    Jie, Q
    Guijin, Z
    Guoning, H
    [J]. FERTILITY AND STERILITY, 2005, 84 : S301 - S301
  • [10] Efficacy and Safety of the Biosimilar Recombinant Human Parathyroid Hormone Cinnopar® in Postmenopausal Osteoporotic Women: A Randomized Double-blind Clinical Trial
    Tabatabaei-Malazy, Ozra
    Norani, Masumeh
    Heshmat, Ramin
    Qorbani, Mostafa
    Vosoogh, Afsaneh
    Afrashteh, Behnaz
    Kahkeshan, Farzin
    Ajami, Arman
    Larijani, Bagher
    [J]. IRANIAN JOURNAL OF PUBLIC HEALTH, 2018, 47 (09) : 1335 - 1343
12345